Understanding the clinical practice of treatment of cardiac rhythm disorders all over the
world and understanding the clinical outcomes of the treatment with its cardiac rhythm
products in real world patient population is essential for Medtronic to be able to
effectively develop new products and adjust existing products. In addition Medtronic is
committed to monitor the safety of its products throughout the entire life cycle to ensure
maximum product reliability.
The Panorama 2 registry will enable Medtronic to increase data collection of clinical
practice with Medtronic implantable Cardiac Rhythm and Disease Management (CRDM) devices in
various regions across the world and on product reliability of its CRDM devices.